FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreThe American College of Radiology® (ACR®) continues its advocacy in the surprise patient billing arena. Congress in 2020 passed the ACR-supported No Surprises Act (NSA), a law that exempts patients from surprise medical bills for certain out-of-network services they received and creates an equitable independent dispute resolution (IDR) process to resolve payment disputes between healthcare providers and insurers.
The IDR process was to use a qualified payment amount (QPA), but the initial regulations issued by federal agencies to implement the NSA were problematic because they ignored the law’s intent in establishing the process. This led to multiple ACR-supported lawsuits filed by the Texas Medical Association (TMA).
The U.S. Court of Appeals for the Fifth Circuit this month voted to reconsider part of the only pending challenge (TMA III) to the federal government’s implementation of the NSA. The appellate judges will rehear as a full court certain aspects of the TMA III case that involve TMA’s challenge to the government’s methodology for calculating the QPA.
A three-judge panel in October partly ruled for the government in the TMA III case, deciding that it acted lawfully by including in the QPA calculation services that a physician does not provide to patients. However, TMA maintains that the panel misread the NSA’s statutory provisions regarding the QPA calculation, particularly of “ghost rates” for such services. Physicians who do not render a service have little incentive to negotiate a rate for those services, which makes these ghost rates generally lower than they would be through a customary, motivated negotiation. Therefore, TMA petitioned the full court to rehear that portion of the panel’s decision.
In this new phase of TMA III, the entire Fifth Circuit will address whether the government’s QPA calculation rules are unlawful because they require insurers to (i) include “ghost” rates agreed to by physicians for services they do not “provide” as the statute defines that term; and (ii) exclude incentive payments from the “total maximum payment” used to calculate the QPA.
TMA and the government must submit their opening and reply briefs by Sept. 2. ACR, along with the American Society of Anesthesiologists and the American College of Emergency Physicians, intends to submit an amicus brief to the appellate court this summer.
If you have questions or would like more information, contact Tom Hoffman, ACR Executive Vice President, Governance and Membership Services, or Susannah Jones, ACR Principal Attorney.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more